Single Ascending Dose Study of ALA-1000
NCT04122755
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Opioid-use Disorder
Interventions
DRUG:
ALA-1000
DRUG:
buprenorphine sublingual film
Sponsor
Alar Pharmaceuticals Inc.